Racura Oncology (ASX:RAC) Beginning Cash Position: A$13.67 Mil (As of Dec. 2025)


ASX:RAC Racura Oncology Ltd ASX:RAC
31 GF Score
Price A$2.14
View Full Analysis

What is Racura Oncology Beginning Cash Position?

Racura Oncology ASX:RAC +0.94% 31 Beginning Cash Position is A$13.67 Mil as of Dec. 2025. GuruFocus rates ASX:RAC with a GF Score™ of 31/100.

Racura Oncology's Beginning Cash Position for the quarter that ended in Dec. 2025 was A$13.67 Mil.

Racura Oncology's quarterly Beginning Cash Position increased from Dec. 2024 (A$17.19 Mil) to Jun. 2025 (A$18.78 Mil) but then declined from Jun. 2025 (A$18.78 Mil) to Dec. 2025 (A$13.67 Mil).

Racura Oncology's annual Beginning Cash Position declined from Jun. 2023 (A$33.54 Mil) to Jun. 2024 (A$21.52 Mil) and declined from Jun. 2024 (A$21.52 Mil) to Jun. 2025 (A$17.19 Mil).

Racura Oncology Beginning Cash Position Related Terms

Racura Oncology Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Racura Oncology's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Racura Oncology Beginning Cash Position Chart

Racura Oncology Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.73 9.32 33.54 21.52 17.19

Racura Oncology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.52 13.72 17.19 18.78 13.67
ASX:RAC
31GF Score
Racura Oncology Ltd ASX:RAC
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Racura Oncology Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of A$13.67 Mil mean?
Racura Oncology (ASX:RAC) has a Beginning Cash Position of A$13.67 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Racura Oncology and its competitors.
Is Racura Oncology's Beginning Cash Position too high?
Racura Oncology's current Beginning Cash Position is A$13.67 Mil. Overall, Racura Oncology has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Racura Oncology's Beginning Cash Position compare to VRTX and REGN?
Racura Oncology's Beginning Cash Position of A$13.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Racura Oncology and its competitors. Racura Oncology's current Beginning Cash Position is A$13.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Racura Oncology stock overvalued right now?
Racura Oncology (ASX:RAC) has a current Beginning Cash Position of A$13.67 Mil. The current Beginning Cash Position is A$13.67 Mil. Racura Oncology's overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Racura Oncology (ASX:RAC), the current Beginning Cash Position is A$13.67 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Racura Oncology Business Description

Other Exchanges FN3:Germany
Address 1 Macquarie Place, Level 36, Gateway, Sydney, NSW, AUS, 2000
Racura Oncology Ltd is a developer of an oncology therapeutics platform designed to develop targeted cancer treatments. The company offers precision oncology drug development, biomarker-driven research, and cancer metabolism therapies, enabling healthcare providers and cancer patients to access targeted treatment options with improved therapeutic outcomes.
31GF Score

Get the complete analysis for ASX:RAC

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.14
Price